Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:activities |
inhibits viral DNA synthesis
|
| gptkbp:appointed_by |
oral tablet
|
| gptkbp:approves |
gptkb:1994
gptkb:FDA |
| gptkbp:brand |
Famvir
|
| gptkbp:contraindication |
severe renal impairment
hypersensitivity to famciclovir |
| gptkbp:discovered_by |
gptkb:Hoffmann-La_Roche
|
| https://www.w3.org/2000/01/rdf-schema#label |
famciclovir
|
| gptkbp:indication |
herpes simplex virus infections
varicella-zoster virus infections |
| gptkbp:ingredients |
C14 H19 N5 O4 S
|
| gptkbp:is_used_for |
treatment of cold sores
treatment of herpes zoster treatment of genital herpes |
| gptkbp:manager |
oral
|
| gptkbp:metabolism |
penciclovir
|
| gptkbp:pharmacokinetics |
bioavailability 77%
|
| gptkbp:side_effect |
dizziness
fatigue headache nausea diarrhea |
| gptkbp:type_of |
104227-87-4
|
| gptkbp:bfsParent |
gptkb:HSV-1
gptkb:HSV-2 gptkb:Simplexvirus gptkb:herpes |
| gptkbp:bfsLayer |
5
|